Vigilare Wealth Management Exact Sciences Corp Transaction History

Vigilare Wealth Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 07, 2022	SELL	$72.5 - $100.68 $263,900 - $366,475	-3,640 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$90.24 - $124.05 $47,376 - $65,126	525 Added 16.85%	3,640 $347,000
Q2 2021 Jul 16, 2021	BUY	$93.66 - $139.27 $82,889 - $123,253	885 Added 39.69%	3,115 $387,000
Q1 2021 Apr 29, 2021	BUY	$116.57 - $155.01 $38,468 - $51,153	330 Added 17.37%	2,230 $294,000
Q4 2020 Jan 14, 2021	SELL	$99.61 - $142.12 $109,571 - $156,332	-1,100 Reduced 36.67%	1,900 $252,000
Q3 2020 Oct 15, 2020	SELL	$72.92 - $102.01 $54,690 - $76,507	-750 Reduced 20.0%	3,000 $306,000
Q2 2020 Jul 20, 2020	SELL	$55.75 - $92.75 $50,175 - $83,475	-900 Reduced 19.35%	3,750 $326,000
Q1 2020 May 04, 2020	BUY	$37.9 - $104.44 $58,707 - $161,777	1,549 Added 49.95%	4,650 $270,000
Q4 2019 Feb 13, 2020	BUY	$77.66 - $99.74 $240,823 - $309,293	3,101 New	3,101 $293,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.